DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Keveyis is a drug marketed by Strongbridge Us and is included in one NDA.
The generic ingredient in KEVEYIS is dichlorphenamide. There are three drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the dichlorphenamide profile page.
Summary for KEVEYIS
|Finished Product Suppliers / Packagers:||2|
|Raw Ingredient (Bulk) Api Vendors:||85|
|Formulation / Manufacturing:||see details|
|Drug Prices:||Drug price information for KEVEYIS|
|What excipients (inactive ingredients) are in KEVEYIS?||KEVEYIS excipients list|
|DailyMed Link:||KEVEYIS at DailyMed|
DrugPatentWatch® Estimated Generic Entry Opportunity Date for KEVEYIS
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
|Applicant||Tradename||Generic Name||Dosage||NDA||Approval Date||TE||Type||RLD||RS||Patent No.||Patent Expiration||Product||Substance||Delist Req.||Exclusivity Expiration|
|Strongbridge Us||KEVEYIS||dichlorphenamide||TABLET;ORAL||011366-002||Aug 7, 2015||RX||Yes||Yes||Try Before You Buy||Try Before You Buy||Try Before You Buy|
|>Applicant||>Tradename||>Generic Name||>Dosage||>NDA||>Approval Date||>TE||>Type||>RLD||>RS||>Patent No.||>Patent Expiration||>Product||>Substance||>Delist Req.||>Exclusivity Expiration|